Abstract:previous knowledge must be rearranged.'' new notions are continually ''revealed to us in whose light all our −− according to Waugh −− science, as in youth rapamycin analog everolimus in children with HGPS and may offer insights into normal aging as well. Thus, in small RNAs enhanced progerin accumulation. The new work has helped to form the basis for a clinical trial of the which inhibited the formation of insoluble aggregates. Blocking the expression of an autophagy-related gene with that rapamycin treatment increased clearance of soluble progerin by activating the autophagic-lysosomal pathway, reduced nuclear blebbing relative to untreated cells. Mechanistic experiments in normal human fibroblasts revealed Indeed, HGPS cells treated with rapamycin showed enhanced progerin degradation, slowed senescence, and resulting cellular quirks. tested whether rapamycin also helps to rid HGPS cells of progerin build-up and to remedy the et al. Thus, Cao a process by which cells clear junk protein and trashed organelles. −− these disorders by stimulating macroautophagy several neurodegenerative diseases, and there is some evidence that rapamycin might be useful in the treatment of and the characteristic accumulation of insoluble progerin in the cytoplasm. Protein aggregation is also a hallmark of blemishes, including slowed growth, an abbreviated life span, nuclear blebbing (bulging of the nuclear membrane), progerin, which accumulates as a person ages. Skin cells (fibroblasts) from HGPS patients display a variety of havoc on cellular form and function. Several studies indicate that normal human cells also express tiny amounts of that accumulates in HGPS cells and wreaks −− called progerin −− improperly processed version of the lamin A protein point mutation in the gene that encodes the nuclear structural protein lamin A. This genetic defect creates an of the skin by 1 or 2 years of age, and heart disease and stroke often by the age of 12. The disease is caused by a Children with HGPS display many of the phenotypes we associate with aging: hair loss, bone deficits, hardening the possibility that rapamycin might be repurposed for the treatment of this dire disease. reveal that the drug reverses disease-distinguishing defects in cells from HGPS patients. These findings raise et al. normal aging process, the versatile drug rapamycin has been shown to extend longevity in animal models. Now, Cao genetic disease characterized by premature aging and death in adolescence or the teen years. In studies of the a lost more swiftly or more dramatically than in children suffering from Hutchinson-Gilford progeria syndrome (HGPS), , in no case is youth cri de coeur quickly, how irrecoverably lost'' is the bloom. Although every adult can relate to this , Evelyn Waugh reminisces about ''the langor of youth'' and laments ''how Brideshead Revisited In the novel The Young and the Youthless

Kan Cao Clearance in Hutchinson-Gilford Progeria Syndrome Cells Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein

Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.

Rapamycin Activates Autophagy in Hutchinson-Gilford Progeria Syndrome

Rapamycin Activates Autophagy in Hutchinson-Gilford Progeria Syndrome: Implications for Normal Aging and Age-Dependent Neurodegenerative Disorders.

Molecular insights into the premature aging disease progeria

[Progerin and Its Role in Accelerated and Natural Aging]

A Therapeutic Target for Vascular Protection in Hutchinson–Gilford Progeria Syndrome

All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype

A Targeted Antisense Therapeutic Approach for Hutchinson–Gilford Progeria Syndrome

Effects of Rapamycin Induced Cellular Autophagy in Aging-Related Diseases

Hutchinson–Gilford Progeria Syndrome: A Premature Aging Disease

Mechanisms of Angiogenic Incompetence in Hutchinson-Gilford Progeria Via Downregulation of Endothelial NOS.

Correlated Alterations in Genome Organization, Histone Methylation, and DNA–lamin A/C Interactions in Hutchinson-Gilford Progeria Syndrome

The Accumulation of Progerin Underlies the Loss of Aortic Smooth Muscle Cells in Hutchinson-Gilford Progeria Syndrome

The Pathogenic Mechanisms and Therapeutic Strategies of Hutchinson-Gilford Progeria Syndrome

Progeria-based vascular model identifies networks associated with cardiovascular aging and disease

Progerin and Telomere Dysfunction Collaborate to Trigger Cellular Senescence in Normal Human Fibroblasts

Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis

Vascular senescence in progeria: role of endothelial dysfunction

Nucleolar expansion and elevated protein translation in premature aging

A Lamin A Protein Isoform Overexpressed in Hutchinson–Gilford Progeria Syndrome Interferes with Mitosis in Progeria and Normal Cells